These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 777003)

  • 61. Developments in mucosal influenza virus vaccines.
    Kuno-Sakai H; Kimura M; Ohta K; Shimojima R; Oh Y; Fukumi H
    Vaccine; 1994 Nov; 12(14):1303-10. PubMed ID: 7856295
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
    Couch RB; Kasel JA; Gerin JL; Schulman JL; Kilbourne ED
    J Infect Dis; 1974 Apr; 129(4):411-20. PubMed ID: 4593871
    [No Abstract]   [Full Text] [Related]  

  • 63. Measuring antibody responses to a live attenuated influenza vaccine in children.
    Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
    Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Live influenza vaccine: screening of attenuated virus strains by a 50% ciliary activity inhibition test in organ cultures of ferret trachea.
    Boudreault A
    Can J Microbiol; 1979 Mar; 25(3):279-84. PubMed ID: 378337
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.
    Treanor JJ; El Sahly H; King J; Graham I; Izikson R; Kohberger R; Patriarca P; Cox M
    Vaccine; 2011 Oct; 29(44):7733-9. PubMed ID: 21835220
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Failure of inactivated influenza vaccine to protect an aged population.
    D'Alessio DJ; Cox PM; Dick EC
    JAMA; 1969 Oct; 210(3):485-9. PubMed ID: 5394377
    [No Abstract]   [Full Text] [Related]  

  • 67. Cell-mediated cytotoxicity following influenza infection and vaccination in humans.
    Reichman RC; Pons VG; Murphy BR; Caplan EA; Dolin R
    J Med Virol; 1979; 4(1):1-14. PubMed ID: 231094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ENHANCED AVIDITY OF INFLUENZA ANTIBODIES AFTER REPEATED CONTACT OF MEN AND ANIMALS WITH A2 INFLUENZA VIRUS.
    ALEXANDROVA GI; YABROV AA; SMORODINTSEV AA
    Acta Virol; 1964 Sep; 8():385-95. PubMed ID: 14209622
    [No Abstract]   [Full Text] [Related]  

  • 69. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune response to combined live influenza virus vaccines administered intranasally.
    Peetermans J; Lamy F; Delem A
    Dev Biol Stand; 1975; 28():340-6. PubMed ID: 1126578
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Study of the avidity of anti-influenza antibodies in sera of convalescents or subjects vaccinated with a live influenza virus vaccine.
    Kallas EV; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1969 Nov; 13(6):489-98. PubMed ID: 4391716
    [No Abstract]   [Full Text] [Related]  

  • 72. Protective efficacy of a live, attenuated, influenza virus vaccine ('Alice' strain).
    Prinzie A; Delem A; Huygelen C
    Postgrad Med J; 1976 Jun; 52(608):395-8. PubMed ID: 785431
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibody responses to influenza vaccines containing A/USSR/90/77.
    Feery BJ; Gallichio HA; Rodda SJ; Hampson AW
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):335-44. PubMed ID: 394734
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of live attenuated influenza A/Scotland/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus.
    Betts RF; Douglas RG; Roth FK; little JW
    J Infect Dis; 1977 Dec; 136(6):746-53. PubMed ID: 925382
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines.
    Mogabgab WJ; Leiderman E
    JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268
    [No Abstract]   [Full Text] [Related]  

  • 76. [The influenza virus and other viruses. Antiinfluenza vaccine adjuvants. The hemagglutination phenomenon. Non-specific inhibition. II].
    LACORTE JG
    Rev Bras Med; 1960 Apr; 17():334-8. PubMed ID: 13758108
    [No Abstract]   [Full Text] [Related]  

  • 77. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influenza B in the spring of 1965.
    Mascoli CC; Leagus MB; Hilleman MR
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):952-60. PubMed ID: 5959041
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effect of group ABO blood factors on the character of the vaccinal process in subjects vaccinated with live influenza divaccine].
    Frolov VK; Sokhin AA; Sotnik AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):51-4. PubMed ID: 4830393
    [No Abstract]   [Full Text] [Related]  

  • 80. [Dynamics of formation in influenza of cysteine-sensitive and resistant antibodies].
    Smagulov KZ; Bol'bot VI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):54-7. PubMed ID: 4830394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.